Cedirogant in adults with psoriasis: a phase 2, randomized, placebo-controlled clinical trial.

Stephen TyringAngela MooreAkimchi MoritaH Chih-Ho HongIn-Ho SongJason EcclestonGweneth LevyMohamed-Eslam F MohamedYuli QianTianshuang WuAnqi PanKinjal HewKim A Papp

Published in: Clinical and experimental dermatology (2024)

Patients with psoriasis who received cedirogant showed PASI improvement and cedirogant was generally well tolerated. Results should be interpreted in the context of early study termination. Cedirogant development has been discontinued.

Keyphrases

double blind
placebo controlled
clinical trial
phase ii
phase iii
open label
study protocol
atopic dermatitis
phase ii study
randomized controlled trial
squamous cell carcinoma